| 1. | A low-iron-available polyphenol-enriched carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes 2003; 52:1204–1209. ... conventional protein-restricted diet at slowing the progression of diabetic nephropathy. Foods rich in polyphenols include olive oil green tea ... |
| 2. | are the first-line agents for reducing the risk of diabetic nephropathy. For patients intolerant to these agents non-dihydropyridine calcium antagonists ... RCTs or time-controlled studies with nonrandomized crossover design in patients with diabetic nephropathy revealed that dietary protein restriction effectively slows the progression ... |
| 3. | (ACE) inhibitor in preventing the progression of diabetic nephropathy. In the age of biases with drug company–sponsored ... be non-inferior to the ACE inhibitor in preventing diabetic nephropathy. The reader must now decide if this “as good ... |
| 4. | The evidence is good that ARBs delay the progression of type 2 diabetic nephropathy. Although more studies have looked at ARBs than ACE ... The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. ... |
| 5. | possibility of further benefit in prevention and treatment of diabetic nephropathy by maximizing doses of ACE inhibitors or ARBs and even ... receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial. ... |
| 6. | Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. ... This was a secondary analysis of the Irbesartan Diabetic Nephropathy Trial which evaluated renal protection. ... |
| 7. | is a reliable marker for the presence of diabetic nephropathy in both patients with type 1 (insulin-dependent) ... (ACEIs) slow or prevent the progression of diabetic nephropathy in patients with MA. The latter benefit occurs ... |
| 8. | Ahmad J Siddiqui MA Ahmad H. Effective postponement of diabetic nephropathy with enalapril in type II diabetes patients with microalbuminuria. ... The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456–62. ... |
| 9. | For those intolerant to ACE inhibitors and ARBs what is the best therapy for reducing the risk of diabetic nephropathy? ... For those intolerant to ACE inhibitors and ARBs what is the best therapy for reducing the risk of diabetic nephropathy? ... |
| 10. | For those intolerant to ACE inhibitors and ARBs what is the best therapy for reducing the risk of diabetic nephropathy? ... |
;toggleImage('BtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Broaden Your Search;toggleImage('RtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Related Terms